Presidents


Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy



Francesco M. Marincola

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar




nicola mozzillo

Nicola Mozzillo
Director of the Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy




scientific board

Paolo A. Ascierto

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy


Gennaro Ciliberto

Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy



Reinhard Dummer

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland



Bernard A. Fox

Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon



Claus Garbe

Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany


John Kirkwood

John M. Kirkwood
Professor of Clinical and Translational Science, Clinical and Translational Science Institute, University of Pittsburgh, Pennsylvania


Francesco M. Marincola

Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar



Giuseppe Masucci

Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden


Ignacio Melero

Ignacio Melero
Professor of Immunology and Consultant, CIMA, CUN and Medical School, University of Navarra, Pamplona, Spain


Nicola Mozzillo

Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy


Giuseppe Palmieri

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy


Igor Puzanov

Igor Puzanov
Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee



Alessandro Testori

Alessandro Testori
Director of the Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy



magdalena-thurin

Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland








 


For information please contact info@melanomabridge.org